These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25519783)

  • 21. [Monitoring HIV antiretroviral therapy in Africa].
    Holen Ø
    Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1442. PubMed ID: 20731076
    [No Abstract]   [Full Text] [Related]  

  • 22. Timing of antiretroviral drugs during tuberculosis therapy.
    Wilson D; Meintjes G
    N Engl J Med; 2010 Jun; 362(22):2137; author reply 2138-9. PubMed ID: 20519688
    [No Abstract]   [Full Text] [Related]  

  • 23. Benefits of early anti-retroviral therapy in patients with HIV-TB co-infection.
    Rajasekaran S
    Indian J Tuberc; 2009 Jul; 56(3):113-6. PubMed ID: 20349752
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral therapy and tuberculosis: does the regimen matter?
    van Leth F; Wit FW; Hermans SM
    Expert Rev Anti Infect Ther; 2014 Jan; 12(1):5-7. PubMed ID: 24256498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Futility of CD4+ monitoring in HIV-1 patients with CD4+ cell count above 350 cells/μl on suppressive antiretroviral therapy.
    Duncan CJ; Schmid ML; Schwab U; Price DA; Ong E
    AIDS; 2014 Nov; 28(17):2638-9. PubMed ID: 25418545
    [No Abstract]   [Full Text] [Related]  

  • 26. [Blood lipid changes at long-term antiretroviral treatment].
    Snopková S; Jarkovský J; Matýsková M; Povolná K; Polák P; Cvanová M; Husa P
    Vnitr Lek; 2011 May; 57(5):463-71. PubMed ID: 21695927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapy.
    Hsu DC; Kerr SJ; Thongpaeng P; Iampornsin T; Pett SL; Zaunders JJ; Avihingsanon A; Ubolyam S; Ananworanich J; Kelleher AD; Cooper DA
    J Infect; 2014 Apr; 68(4):344-54. PubMed ID: 24325926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.
    ; ; Brinkhof MW; Egger M; Boulle A; May M; Hosseinipour M; Sprinz E; Braitstein P; Dabis F; Reiss P; Bangsberg DR; Rickenbach M; Miro JM; Myer L; Mocroft A; Nash D; Keiser O; Pascoe M; van der Borght S; Schechter M
    Clin Infect Dis; 2007 Dec; 45(11):1518-21. PubMed ID: 17990236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral therapy: need for a long-term view.
    Maniar JK
    Indian J Dermatol Venereol Leprol; 2006; 72(6):401-4. PubMed ID: 17179612
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment outcomes of patients co-infected with HIV and tuberculosis who received a nevirapine-based antiretroviral regimen: a four-year prospective study.
    Manosuthi W; Tantanathip P; Chimsuntorn S; Eampokarap B; Thongyen S; Nilkamhang S; Sungkanuparph S
    Int J Infect Dis; 2010 Nov; 14(11):e1013-7. PubMed ID: 20880733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aseptic meningitis and acute HIV syndrome after interruption of antiretroviral therapy: implications for structured treatment interruptions.
    Worthington MG; Ross JJ
    AIDS; 2003 Sep; 17(14):2145-6. PubMed ID: 14502028
    [No Abstract]   [Full Text] [Related]  

  • 32. CD4/CD8 Cell Ratio in Acute HIV Infection and the Impact of Early Antiretroviral Therapy.
    Hoenigl M; Chaillon A; Little SJ
    Clin Infect Dis; 2016 Aug; 63(3):425-6. PubMed ID: 27143670
    [No Abstract]   [Full Text] [Related]  

  • 33. Assessment of the effectiveness of antiretroviral treatment among HIV-infected adults: a prospective cohort study in Yunnan Province, 2004-2010.
    Lu L; Ma W; Jia M; Wang L; Guo W; Peng Z; Yu R; Wang N
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):161-2. PubMed ID: 25400262
    [No Abstract]   [Full Text] [Related]  

  • 34. Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy.
    Manosuthi W; Kiertiburanakul S; Phoorisri T; Sungkanuparph S
    J Infect; 2006 Dec; 53(6):357-63. PubMed ID: 16487593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of strategies for monitoring the response to antiretroviral therapy in resource-limited settings.
    Phillips AN; Gilks C; Lundgren JD
    Arch Intern Med; 2009 May; 169(9):904; author reply 904-5. PubMed ID: 19433706
    [No Abstract]   [Full Text] [Related]  

  • 36. Study on CD4 cell responses in HIV infected subjects in Nepal.
    Tiwari BR; Ghimire P; Malla S
    Nepal Med Coll J; 2008 Mar; 10(1):45-7. PubMed ID: 18700632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with late Human Immunodeficiency Virus (HIV) diagnosis among peoples living with it, Northwest Ethiopia: hospital based unmatched case-control study.
    Aniley AB; Ayele TA; Zeleke EG; Kassa AA
    BMC Public Health; 2016 Oct; 16(1):1076. PubMed ID: 27733197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary: Operational Guidance in the 2013 WHO consolidated antiretroviral guidelines.
    Assefa Y; Pillay Y; Van Damme W
    AIDS; 2014 Mar; 28 Suppl 2():S171-3. PubMed ID: 24849477
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunological recovery and antiretroviral therapy in HIV-1 infection.
    Battegay M; Nüesch R; Hirschel B; Kaufmann GR
    Lancet Infect Dis; 2006 May; 6(5):280-7. PubMed ID: 16631548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral therapy in early HIV infection.
    Walker BD; Hirsch MS
    N Engl J Med; 2013 Jan; 368(3):279-81. PubMed ID: 23323905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.